Document is current
Any future updates will be listed below
-
Authors
Dzienis, Marcin https://orcid.org/0000-0002-8475-3282
Mojebi, Ali https://orcid.org/0000-0003-2318-8627
Keeping, Sam https://orcid.org/0000-0002-4281-1536
Black, Christopher M. https://orcid.org/0000-0003-2934-108X
Giezek, Hilde
Naicker, Niroshini
Vanetta, Chiara https://orcid.org/0000-0002-3741-6208
Park, Julie E. https://orcid.org/0000-0002-8054-5443
Chan, Keith
Merchant, Sanjay
Zheng, Dandan https://orcid.org/0000-0002-6460-4036
-
Funding
Funding for this research was provided by:
Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
- License Information
-
More Information
Article History
Received: 20 November 2024
Accepted: 11 February 2025
First Online: 24 April 2025
Declarations
:
: Marcin Dzienis declares a consultant or advisory role with MSD, Bristol-Myers Squibb, and Novartis and has received payment or honoraria for presentations and serving as a speaker from MSD, Novartis, AstraZeneca, and Bristol-Myers Squibb, and for education support from Pierre Fabre and MSD. Christopher M. Black, Sanjay Merchant, and Dandan Zheng are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and are shareholders in Merck & Co., Inc., Rahway, NJ, USA. Hilde Giezek and Chiara Vanetta are employees of MSD subsidiaries of Merck & Co., Inc., Rahway, NJ, USA. Niroshini Naicker is an employee of an MSD subsidiary of Merck & Co., Inc., Rahway, NJ, USA and is a shareholder in Merck & Co., Inc., Rahway, NJ, USA. Ali Mojebi, Sam Keeping, Julie E. Park, and Keith Chan are employed by the company Precision AQ, which received funding from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
